Rejoyn, the first digital prescription app for major depressive disorder, was just cleared by the US Food and Drug ...
Known as Rejoyn, the treatment is a smartphone app that's designed to be used along with antidepressant medications. "Rejoyn represents a novel and exciting adjunctive treatment option to address ...
Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
Otsuka Pharma and Click Therapeutics' Rejoyn (formerly CT-152) app – which is used to help people with MDD manage their emotions more effectively – can be unlocked with a prescription from a ...